postpartum depression

Sage’s recent trial failure adds pressure to its two-drug Biogen collab
Pharma Voice
Mon, 07/29/24 - 10:29 am
SAGE Therapeutics
Biogen
clinical trials
SAGE-324
essential tremor
Zurzuvae
postpartum depression
Reunion raises over $100M to build a better psychedelic drug
BioPharma Dive
Fri, 05/3/24 - 11:18 am
Reunion Neuroscience
psychedelics
postpartum depression
funding
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive
Wed, 04/24/24 - 09:18 pm
Biogen
postpartum depression
Zurzuvae
A new $16,000 postpartum depression drug is here. How will insurers handle it?
Medical Marketing and Media
Wed, 03/13/24 - 11:11 am
zuranolone
postpartum depression
SAGE Therapeutics
Sage offers encouraging details on launch of new postpartum depression pill
BioPharma Dive
Wed, 02/14/24 - 06:42 pm
SAGE Therapeutics
postpartum depression
drug launches
Zurzuvae
Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
Reuters
Tue, 11/7/23 - 09:55 am
Biogen
SAGE Therapeutics
postpartum depression
drug pricing
Zurzuvae
Brii Biosciences aims to come up big where Sage and Biogen fell short
Pharma Voice
Mon, 08/21/23 - 06:53 pm
Brii Biosciences
depression
SAGE Therapeutics
Biogen
BRII-296
postpartum depression
Biogen, Sage's postpartum depression approval overshadowed by larger rejection
Fierce Pharma
Mon, 08/7/23 - 12:01 pm
SAGE Therapeutics
Biogen
FDA
Zurzuvae
postpartum depression
major depressive disorder
FDA Approves Biogen, Sage’s Zurzuvae as First Pill for Postpartum Depression
BioSpace
Sun, 08/6/23 - 09:39 pm
Biogen
SAGE Therapeutics
FDA
Zurzuvae
postpartum depression
major depressive disorder
zuranolone
FDA Action Alert: Mesoblast, Sage/Biogen and Galera
BioSpace
Mon, 07/31/23 - 10:05 am
FDA
graft vs host disease
head and neck cancer
postpartum depression
major depressive disorder
Mesoblast
remestemcel-L
Biogen
SAGE Therapeutics
zuranolone
Galera Therapeutics
avasopasem manganese
Go or no go? Biogen and Astellas head towards key PDUFAs
EP Vantage
Sat, 07/29/23 - 10:45 pm
FDA
Astellas
Zimura
Biogen
SAGE Therapeutics
zuranolone
major depressive disorder
postpartum depression
geographic atrophy
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
FDA says no adcomm planned for Biogen, Sage's depression drug
Seeking Alpha
Wed, 03/8/23 - 09:47 pm
Biogen
SAGE Therapeutics
FDA
zuranolone
major depressive disorder
postpartum depression
Biogen, Sage Get FDA Priority Review of Zuranolone
Marketwatch
Mon, 02/6/23 - 10:47 am
Biogen
SAGE Therapeutics
FDA
zuranolone
priority review
postpartum depression
major depressive disorder
Sage, Biogen post fresh phase 3 depression data as FDA filing nears completion
Fierce Biotech
Mon, 10/17/22 - 10:39 am
SAGE Therapeutics
Biogen
zuranolone
postpartum depression
clinical trials
Sage, Biogen drug meets goal in postpartum depression study
BioPharma Dive
Wed, 06/1/22 - 07:32 pm
SAGE Therapeutics
Biogen
FDA
zuranolone
postpartum depression
Biogen and Sage Present Positive Data for Breakthrough Depression Therapy
BioSpace
Mon, 10/4/21 - 10:55 pm
Biogen
SAGE Therapeutics
major depressive disorder
postpartum depression
clinical trials
zuranolone
These Digital Health and Medtech Companies Are Changing the Game in Maternal Health
Medical Devices and Diagnostics Industry
Fri, 05/7/21 - 10:46 am
digital health
devices
Medtech
maternal health
Alydia Health
Memora Health
Omaiven Health
Progenity
Pronto
postpartum depression
preeclampsia
Sage's new drug starts slow, as Wall Street waits for depression data
Biopharma Dive
Wed, 11/13/19 - 11:25 pm
SAGE Therapeutics
postpartum depression
Zulresso
drug launches
Marinus leaves the way clear for Sage
EP Vantage
Wed, 07/24/19 - 10:31 am
Marinus Pharma
SAGE Therapeutics
ganaxolone
clinical trials
postpartum depression

Pages